9 patents
Utility
Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
2 Nov 23
A dry powder inhalation treatment for pulmonary arterial hypertension includes a dose of dry particles comprising greater than 25 micrograms of treprostinil enclosed in a capsule.
Robert Frank Roscigno, Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor
Filed: 12 Jul 23
Utility
Dry powder treprostinil for the treatment of pulmonary hypertension
5 Sep 23
A dry powder inhalation treatment for pulmonary arterial hypertension includes a dose of dry particles comprising greater than 25 micrograms of treprostinil enclosed in a capsule.
Robert Frank Roscigno, Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor
Filed: 30 Jul 21
Utility
Dry powder treprostinil for the treatment of pulmonary hypertension
5 Sep 23
A dry powder inhalation treatment for pulmonary arterial hypertension includes a dose of dry particles comprising greater than 25 micrograms of treprostinil enclosed in a capsule.
Robert Frank Roscigno, Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor
Filed: 30 Jul 21
Utility
Dry powder treprostinil for the treatment of pulmonary hypertension
1 Aug 23
A dry powder inhalation treatment for pulmonary arterial hypertension includes a dose of dry particles comprising greater than 25 micrograms of treprostinil enclosed in a capsule.
Robert Frank Roscigno, Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor
Filed: 25 Nov 20
Utility
Dry powder treprostinil for the treatment of pulmonary hypertension
30 May 23
A dry powder inhalation treatment for pulmonary arterial hypertension includes a dose of dry particles comprising greater than 25 micrograms of treprostinil enclosed in a capsule.
Robert Frank Roscigno, Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor
Filed: 13 Apr 22
Utility
Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
18 Aug 22
A dry powder inhalation treatment for pulmonary arterial hypertension includes a dose of dry particles comprising greater than 25 micrograms of treprostinil enclosed in a capsule.
Robert Frank Roscigno, Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor
Filed: 13 Apr 22
Utility
Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
18 Nov 21
A dry powder inhalation treatment for pulmonary arterial hypertension includes a dose of dry particles comprising greater than 25 micrograms of treprostinil enclosed in a capsule.
Robert Frank Roscigno, Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor
Filed: 30 Jul 21
Utility
Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
18 Nov 21
A dry powder inhalation treatment for pulmonary arterial hypertension includes a dose of dry particles comprising greater than 25 micrograms of treprostinil enclosed in a capsule.
Robert Frank Roscigno, Brian T. Farrer, Jacob J. Sprague, Benjamin Maynor
Filed: 30 Jul 21
Utility
Pharmaceutical Compositions of Ribavirin
14 Oct 21
Disclosed are inhalable antiviral pharmaceutical compositions of ribavirin, methods of producing the same, and the use of such compositions in the treatment of virally associated respiratory infections, and associated diseases and conditions.
Philip Charles DELL'ORCO, Brian T FARRER, Zhi HONG, Christopher D ROBERTS, John Robert SAVAGE, Jacob J SPRAGUE, Yongcai WANG
Filed: 18 Nov 16
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first